SOX2 and neoplasm: First, in the inducible model, it has been shown that the expression of oncogenic β-catenin in SOX2 + pituitary stem cells at different ages results in a significant reduction in tumour formation when comparing induction in aged (6–9 months old) vs. young (4–6 weeks old) mice.